Company news

Impact Therapeutics, Inc. Class H (HKEX:7630) news

Impact Therapeutics, Inc. Class H news releases on 6ix. Latest, Jul 31, 2026: IMPACT Therapeutics Signs Exclusive License Agreement with Pharmanovia…

View Impact Therapeutics, Inc. Class H →

Press releases & updates

IMPACT Therapeutics Signs Exclusive License Agreement with Pharmanovia for Senaparib in Europe, Middle East and North Africa, Australia and New Zealand

July 31, 2026

ARTICLES OF ASSOCIATION

June 25, 2026

Next Day Disclosure Return

June 10, 2026